Alkermes Plc (ALKS)
47.02
+0.04
(+0.09%)
USD |
NASDAQ |
Nov 13, 16:00
47.02
0.00 (0.00%)
After-Hours: 19:59
Alkermes Shareholders Equity (Quarterly) : 1.865B for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.865B |
| June 30, 2026 | 1.809B |
| March 31, 2026 | 1.752B |
| December 31, 2025 | 1.819B |
| September 30, 2025 | 1.733B |
| June 30, 2025 | 1.625B |
| March 31, 2025 | 1.512B |
| December 31, 2024 | 1.465B |
| September 30, 2024 | 1.292B |
| June 30, 2024 | 1.284B |
| March 31, 2024 | 1.255B |
| December 31, 2023 | 1.203B |
| September 30, 2023 | 1.356B |
| June 30, 2023 | 1.280B |
| March 31, 2023 | 1.006B |
| December 31, 2022 | 1.044B |
| September 30, 2022 | 1.043B |
| June 30, 2022 | 1.082B |
| March 31, 2022 | 1.075B |
| December 31, 2021 | 1.113B |
| September 30, 2021 | 1.096B |
| June 30, 2021 | 1.098B |
| March 31, 2021 | 1.051B |
| December 31, 2020 | 1.067B |
| September 30, 2020 | 1.084B |
| Date | Value |
|---|---|
| June 30, 2020 | 1.062B |
| March 31, 2020 | 1.063B |
| December 31, 2019 | 1.085B |
| September 30, 2019 | 1.068B |
| June 30, 2019 | 1.091B |
| March 31, 2019 | 1.102B |
| December 31, 2018 | 1.171B |
| September 30, 2018 | 1.151B |
| June 30, 2018 | 1.158B |
| March 31, 2018 | 1.156B |
| December 31, 2017 | 1.203B |
| September 30, 2017 | 1.187B |
| June 30, 2017 | 1.202B |
| March 31, 2017 | 1.217B |
| December 31, 2016 | 1.209B |
| September 30, 2016 | 1.210B |
| June 30, 2016 | 1.244B |
| March 31, 2016 | 1.265B |
| December 31, 2015 | 1.314B |
| September 30, 2015 | 1.367B |
| June 30, 2015 | 1.399B |
| March 31, 2015 | 1.420B |
| December 31, 2014 | 1.397B |
| September 30, 2014 | 1.334B |
| June 30, 2014 | 1.352B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amarin Corp. Plc | 444.41M |
| Prothena Corp. Plc | 268.84M |
| Cue Biopharma, Inc. | 2.31M |
| ACADIA Pharmaceuticals, Inc. | 1.387B |
| Alnylam Pharmaceuticals, Inc. | 3.604B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.436B |
| Total Liabilities (Quarterly) | 2.571B |
| Debt to Equity Ratio | 0.8425 |
| Current Ratio | 2.425 |
| Net Debt Paydown Yield | -4.40% |